USMLE® Step 1 style questions USMLE
USMLE® Step 2 style questions USMLE
An 82-year-old man comes to the office because of generalized fatigue for 2 years. He states that over the last year he has also had some difficulty walking and using his hands. He finds that his hands now shake, especially when he is watching television. Examination shows a thin appearing man with reduced facial expressions. He has a broad-based, hesitant gait, and a tremor of the left hand. Which of the following provides the best explanation for the cause of this patient's movement symptoms?
Parkinson’s disease, which is sometimes called Parkinson disease, Parkinson’s, or PD, is a movement disorder where the dopamine-producing neurons in the substantia nigra of the brain undergo degeneration.
Parkinson’s is one of the most common neurological disorders.
It’s a progressive, adult-onset disease, and it gets more common with age.
Most of the time, there’s no known cause. But in a few cases, there might be a genetic cause, like mutations in the PINK1, parkin, or alpha synuclein genes, and in rare cases, Parkinsonian symptoms may be caused by MPTP, a toxic impurity that can be found in the recreational drug MPPP or desmethylprodine, which is a synthetic opioid.
In other people, one or more risk factors, rather than a single outright cause, might contribute to Parkinson’s, for example pesticide exposure or DNA variants in genes like LRRK2.
No matter the cause is, Parkinson’s derives from the death of dopamine-producing, or dopaminergic, neurons in the substantia nigra.
The name substantia nigra means “black substance,” since it is darker than other brain regions when you look at a slice of the brain on an autopsy.
We usually refer to the substantia nigra as if it’s in a single location, but there are actually two of these regions in the brain, one on each side of the midbrain.
In Parkinson’s, these darkened areas of substantia nigra gradually disappear.
Under a microscope, Lewy bodies, which are eosinophilic, round inclusions made of alpha-synuclein protein are present in the affected substantia nigra neurons before they die.
The substantia nigra actually can be split into two sub-regions.
First, there’s the pars reticulata, which receives signals from another part of the basal ganglia called the striatum, which is a term for the caudate and putamen put together, and relays messages to the thalamus via neurons rich in the neurotransmitter GABA, also known as gamma-aminobutyric acid.
Second, there’s the pars compacta, and this is the part of the substantia nigra affected in Parkinson’s.
The pars compacta sends messages to the striatum via neurons rich in the neurotransmitter dopamine, forming the nigrostriatal pathway, which helps to stimulate the cerebral cortex and initiate movement.
Therefore, when substantia nigra pars compacta neurons die, the individual may be in a hypokinetic or low movement state which is commonly seen in Parkinson’s.
In addition to simply initiating movements, the substantia nigra helps to calibrate and fine tune the way that movements happen, which leads to the clinical features of Parkinson’s.
First there’s tremor, which is an involuntary shakiness most noticeable in the hands—characteristically called a “pill-rolling” tremor because it looks like someone rolling a pill between their thumb and index finger.
This is a “resting tremor,” meaning it is present at rest and diminishes with intentional movement.
Next there’s rigidity, which refers to stiffness that can appear as “cogwheel” rigidity, which is when there are a series of catches or stalls as a person’s arms or legs are passively moved by someone else.
Rigidity is also responsible for the stooped posture and an almost expressionless face that some individuals with Parkinson’s might have.
- "Robbins Basic Pathology" Elsevier (2017)
- "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
- "Pathophysiology of Disease: An Introduction to Clinical Medicine 7/E (ENHANCED EBOOK)" McGraw Hill Professional (2014)
- "CURRENT Medical Diagnosis and Treatment 2020" McGraw Hill Professional (2019)
- "Parkinson's disease" The Lancet (2015)
- "Parkinson's disease" The Lancet (2004)